Celgene's Pipeline In Question After GED Failure
October 20, 2017 at 11:44 AM EDT
After announcing the termination of its mongerson program for Crohn’s disease, Celgene Corporation (NASDAQ: CELG) is looking more ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.